LINC01513

Across TCGA pan-cancer cohorts, LINC01513 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC01513 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01513 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01513 expression acts as an unfavorable survival marker, although some lineages such as BRCA and SARC show a favorable association.

ACC, LGG, and BRCA are the cancer types where LINC01513 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Quartile	II,III,IV	0.486	0.830	<.001	69	view →
LGG	OS	Median	All	0.337	0.504	<.001	46	view →
BRCA	DFS	Median	III,IV	0.917	0.836	.005	44	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
KIRP	DFS	Tertile	II,III,IV	0.571	0.910	.005	27	view →
SARC	DFS	Quartile	All	0.642	0.451	.004	22	view →
MESO	DFS	Tertile	II,III,IV	0.675	0.275	.012	16	view →
LAML	DFS	Tertile	All	0.605	0.273	.003	14	view →
SKCM	OS	Tertile	III,IV	0.718	0.890	.015	13	view →
TGCT	DFS	Quartile	III,IV	0.505	1.000	.031	12	view →
PAAD	DFS	Tertile	III,IV	0.275	0.809	.017	9	view →
COAD	DFS	Tertile	IV	0.277	0.506	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC01513–ACC (OS)

Open the ACC breakdown →